01-06-2019 | Research Article
Minimal residual disease-directed immunotherapy for high-risk myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation
Published in: Frontiers of Medicine | Issue 3/2019
Login to get access01-06-2019 | Research Article
Published in: Frontiers of Medicine | Issue 3/2019
Login to get access